Please Wait
Applying Filters...
menu
    • menu
    Skyepharma-PSE
    News
    Our patent for MucoTabS has officially been filed

    02 Jan 2026

    // PRESS RELEASE

    Skyepharma French CDMO Drives Growth Through Leadership Change

    06 Nov 2025

    // PRESS RELEASE

    Collaboration Eneapharm & Skyepharma

    13 Aug 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Skyepharma RM

    Contact Supplier

    Website

    PEGS Boston Summit

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/GQ0e9Im32aY?si=o0xfkcMVN68jYcuM
    Left Arrow
    Right Arrow

    Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

    Related CompaniesRelated Companies

    About

    Skyepharma Production SAS is an expert & innovative CDMO in complex OSDs possessing its proprietary technologies of modified release & multilayer tablets. It offers a broad range of services, from early-stage development to industrial manufacturing & packaging. It also has the capacity for oncologic product development & manufacturing, as well as for NCEs, Highly potent molecules, non-sexual hormones, controlled substances, biotechnologies & others. Skyepharma has a proven record of successful projects, with a skilled scientific team which is agile and high-quality oriented. Skyepharma is GMP certified as well as FDA, ANSM & ANVISA approved.
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.